PAUL SCHIMMEL
CIK 1236447 · last filed 2026-05-28
PAUL SCHIMMEL is a corporate insider who has filed 77 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider bought $49.6K of ATYR on May 28, 2026. Across all open-market trades the lifetime net is −$8.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $219.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$219.94M
7
77
-$8.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATYR | Director | 1,421,913 | $0.49 | $702.4K | $49.6K | 2 | 2026-05-28 |
| LIFE | Director | 688,033 | $18.80 | $12.94M | $6.76M | 38 | 2025-10-09 |
| Forte Biosciences, Inc. (TOCA) Delisted | Director | 1,806 | — | — | $100.0K | 4 | 2019-10-04 |
| ALNY | Director | 316,996 | $288.41 | $91.42M | -$15.34M | 27 | 2019-07-02 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | 352,022 | — | — | -$195.6K | 2 | 2007-12-04 |
| ALKS | Director | 360,600 | $50.50 | $18.21M | $0 | 1 | 2007-06-19 |
| RGEN | Director | 665,106 | $145.34 | $96.67M | $0 | 2 | 2007-06-18 |
Recent Filings
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | ATYR | Buy (P) | +100,000 | $49.6K | EDGAR |
| 2026-05-13 | ATYR | Grant (A) | — | $0 | EDGAR |
| 2025-10-09 | LIFE | Buy (P) | +1,000,000 | $911.8K | EDGAR |
| 2025-05-02 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2024-07-24 | LIFE | Buy (P) | +100,000 | $184.6K | EDGAR |
| 2024-05-23 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2023-05-11 | LIFE | Buy (P) | +200,000 | $450.0K | EDGAR |
| 2023-04-28 | LIFE | Exer (M) | +6,000 | $0 | EDGAR |
| 2022-04-28 | LIFE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.